Gursimran Singh - Ajooni Biotech CEO Director
| AJOONI Stock | 7.83 0.04 0.51% |
Insider
Gursimran Singh is CEO Director of Ajooni Biotech Limited
| Age | 36 |
| Address | D-118, Industrial Area, Mohali, India, 160055 |
| Phone | 91 17 2502 0758 |
| Web | https://www.ajoonibiotech.com |
Ajooni Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0354 %, meaning that it generated $0.0354 on every $100 dollars invested by stockholders. Ajooni Biotech's management efficiency ratios could be used to measure how well Ajooni Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ajooni Biotech's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 339.4 M, whereas Non Current Assets Total are forecasted to decline to about 80.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Charanjit Attra | State Bank of | N/A | |
| Bhagwan Pandey | Coal India Limited | N/A | |
| Pawan Kapil | Reliance Industries Limited | 77 | |
| Ashwini Tewari | State Bank of | 57 | |
| Vinay Razdan | HDFC Bank Limited | 58 | |
| Challa Setty | State Bank of | 59 | |
| Arun B | Oil Natural Gas | 62 | |
| Srikanth Venkatachari | Reliance Industries Limited | 58 | |
| Vivek Tongaonkar | Oil Natural Gas | 58 | |
| Veera Reddy | Coal India Limited | N/A | |
| Anurag Sharma | Oil Natural Gas | 61 | |
| Rajashree R | Tata Consultancy Services | N/A | |
| Pradeep Gaitonde | Tata Consultancy Services | N/A | |
| Kamal Sharma | Oil Natural Gas | 62 | |
| Om Singh | Oil Natural Gas | 60 | |
| Ajit Shetty | HDFC Bank Limited | N/A | |
| Siddhartha Sengupta | State Bank of | 65 | |
| Kedar Shirali | Tata Consultancy Services | N/A | |
| Rajesh Gopinathan | Tata Consultancy Services | 52 | |
| Madhu Chhibber | HDFC Bank Limited | N/A | |
| BE PGDM | Reliance Industries Limited | 64 | |
Management Performance
| Return On Equity | 0.0354 | ||||
| Return On Asset | 0.0139 |
Ajooni Biotech Leadership Team
Elected by the shareholders, the Ajooni Biotech's board of directors comprises two types of representatives: Ajooni Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ajooni. The board's role is to monitor Ajooni Biotech's management team and ensure that shareholders' interests are well served. Ajooni Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ajooni Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Swati Vijan, Company Officer | ||
| Gursimran Singh, CEO Director | ||
| Partek Singh, WholeTime Director | ||
| Jasjot Singh, MD Chairman |
Ajooni Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ajooni Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0354 | ||||
| Return On Asset | 0.0139 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 791.48 M | ||||
| Shares Outstanding | 99.37 M | ||||
| Price To Book | 1.81 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 800.01 M | ||||
| Gross Profit | 87.45 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ajooni Stock
Ajooni Biotech financial ratios help investors to determine whether Ajooni Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajooni with respect to the benefits of owning Ajooni Biotech security.